Our website uses cookies to improve your on-site experience. By using the website, cookies are being used as described in our Policy Document
Warning: To log in you will need to enable cookies and reload the page (Policy Document)
My ePortfolio Register   

Myeloma Knowledge Exchange 2019 (MyKE Myeloma) /
Diagnosis and detection of smouldering multiple myeloma

10th - 11th May 2019

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 14.05.19
Views: 1009

Dr Elena Zamagni - University of Bologna, Bologna, Italy

Dr Elena Zamagni speaks to ecancer at the 2019 MyKE Myeloma meeting in Barcelona about the diagnostic techniques available in smouldering multiple myeloma.

She emphasises the importance of using novel imaging techniques, rather than whole body X-ray to ensure a clear image of the bone marrow is obtained. These techniques should be also be combined with laboratory tests that measure the levels of serum-free light chains and proteinuria.

Prof Zamagni also discusses some of the risk factors that may contribute to disease progression, which include the presence of myeloma protein, proteinuria, cytogenetic abnormalities and focal lesions - along with diagnostic challenges that clinicians currently face.

ecancer's filming has been kindly supported by Amgen through the ecancer Global Foundation. ecancer is editorially independent and there is no influence over content.

Previous conferences: highlights

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

ecancer Global Foundation